This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Jenny Pingqi Dai: Innovator in Antineoplastic and Antiviral Agents
Introduction
Jenny Pingqi Dai is a prominent inventor based in Hershey, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for AKT (protein kinase B). Her work focuses on creating compounds that serve as antineoplastic and antiviral agents.
Latest Patents
Jenny holds a patent for her invention titled "Inhibitors of AKT (protein kinase B) - 4-[5-(2-Amino-ethanesulfonyl)-isoquinolin-7-yl]-phenol or a pharmaceutically acceptable salt thereof or a hydrate of the compound or the salt thereof." This patent outlines the use of these compounds as Akt inhibitors, which are crucial in the treatment of various diseases.
Career Highlights
Jenny is currently employed at Eli Lilly and Company, where she continues to innovate and contribute to the pharmaceutical industry. Her dedication to research and development has positioned her as a key player in her field.
Collaborations
Throughout her career, Jenny has collaborated with notable colleagues, including Sajan Joseph and Renhua Li. These partnerships have enhanced her research and expanded the impact of her inventions.
Conclusion
Jenny Pingqi Dai is a remarkable inventor whose work in developing AKT inhibitors has the potential to advance treatments for cancer and viral infections. Her contributions to the pharmaceutical industry are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile